Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-069783)

Filing Details

Accession Number:: 0001209191-21-069783
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-15 17:08:23
Reporting Period:: 2021-12-13

Accepted Time:: 2021-12-15 17:08:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1741830	Kronos Bio Inc.	KRON	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1826766	Christopher Dinsmore	C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-13	11,212	$12.36	85,148	No	4	S	Direct
Common Stock	Disposition	2021-12-13	174	$12.82	84,974	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.